New Arthritis Drug Shows Promise in Treating Autoimmune Hair Loss
תומצת מתוך Channel 13 על ידי baba
A drug initially developed for rheumatoid arthritis has been found to stimulate hair regrowth in patients with alopecia areata, an autoimmune cause of hair loss, according to a new study. The treatment's effects last up to three years and are safe, offering new hope for affected patients.
הידיעה ב-6 שורות · תקציר של baba
- A rheumatoid arthritis drug promotes hair regrowth in alopecia areata patients.
- The treatment targets the same autoimmune mechanism causing both conditions.
- Hair regrowth effects last up to three years with a good safety profile.
- The drug is effective only for autoimmune-related hair loss, not other baldness types.
- The discovery offers new hope for patients with alopecia areata.
- Study published in the New England Journal of Medicine confirms these findings.
A recent study published in the New England Journal of Medicine reveals a breakthrough treatment for hair loss caused by the autoimmune disease alopecia areata. Originally developed to treat rheumatoid arthritis, the drug was found to have a side effect that promotes hair regrowth in patients suffering from this specific type of hair loss. Professor Eitan Friedman, head of the Genetic Institute for Early Detection at Assuta Ramat Hahayal, explained in an interview with HaOlam HaBoker that the drug targets the same biological mechanism involved in both rheumatoid arthritis and alopecia areata.
The research is a follow-up study demonstrating that the hair regrowth effect is sustained for up to three years and is safe in terms of side effects. However, the treatment is effective only for hair loss linked to the autoimmune condition alopecia areata and not for other types of baldness. Despite this limitation, the discovery offers significant new hope for patients struggling with this form of hair loss.